We are live on ! Find out more
CRDL

Cardiol Therapeutics
CRDL

19 hedge funds and large institutions have $6.62M invested in Cardiol Therapeutics in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.74% more ownership

Funds ownership: 0% → 3.74% (+3.7%)

Holders
19
Holders Change
+19
Holders Change %
–
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$3.78M
2
Renaissance Technologies
Renaissance Technologies
New York
+$525K
3
Jane Street
Jane Street
New York
+$288K
4
VF
Virtu Financial
New York
+$275K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$190K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Mirae Asset Global Investments
1
Mirae Asset Global Investments
South Korea
$4.3M +$3.78M +1,043,704 New
Renaissance Technologies
2
Renaissance Technologies
New York
$598K +$525K +144,900 New
Jane Street
3
Jane Street
New York
$327K +$288K +79,431 New
VF
4
Virtu Financial
New York
$315K +$275K +75,819 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$217K +$190K +52,435 New
VIA
6
Vident Investment Advisory
Georgia
$208K +$183K +50,566 New
Two Sigma Advisers
7
Two Sigma Advisers
New York
$129K +$113K +31,100 New
Morgan Stanley
8
Morgan Stanley
New York
$112K +$98.2K +27,090 New
MHIC
9
Marble Harbor Investment Counsel
Massachusetts
$91K +$79.7K +22,000 New
Goldman Sachs
10
Goldman Sachs
New York
$79K +$69.2K +19,100 New
Osaic Holdings
11
Osaic Holdings
Arizona
$65K +$57.3K +15,800 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$59K +$51.4K +14,195 New
Bank of America
13
Bank of America
North Carolina
$57K +$50K +13,808 New
FDCDDQ
14
Federation des caisses Desjardins du Quebec
Quebec, Canada
$24.5K +$21.7K +6,000 New
PO
15
Private Ocean
California
$23K +$19.9K +5,500 New
TRCT
16
Tower Research Capital (TRC)
New York
$9K +$7.83K +2,161 New
Toronto Dominion Bank
17
Toronto Dominion Bank
Ontario, Canada
$4K +$3.2K +882 New
PSB
18
Piscataqua Savings Bank
New Hampshire
$4K +$3.62K +1,000 New
TCM
19
Tradewinds Capital Management
Washington
$2K +$1.81K +500 New

CRDL Hedge Fund Activity: Q3 2021 in Review

19 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q3 2021, worth a combined $6.62M.

Buyers outnumbered sellers: 19 funds opened new CRDL positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Mirae Asset Global Investments, opening a new position worth an estimated $3.78M.

  • 19 institutional investors held Cardiol Therapeutics (CRDL) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $6.62M of Cardiol Therapeutics stock for Q3 2021.
  • 19 funds opened new Cardiol Therapeutics positions in Q3 2021 and 0 closed out, a net change of +19 holders.
  • The largest Cardiol Therapeutics buyer in Q3 2021 was Mirae Asset Global Investments, an estimated $3.78M added.

Based on aggregated 13F filings for Q3 2021.